Navigation Links
New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Date:10/11/2007

HAYWARD, Calif., Oct. 11 /PRNewswire/ -- Guava Technologies today launched a new corporate website with an infrastructure focused around its main audiences: Life Scientists, Flow Cytometrists, and Clinicians.

With flow cytometry being an essential tool for cell analysis, Guava Technologies is dedicated to finding innovative ways to make the technology as practical as possible for all life scientists and clinicians who work with cells. This dedication is obvious from the audience-centric organization of the new site, where the main choices on the home page for further investigation are targeted to the unique needs of the company's main markets: Life Science Research (i.e., pharma/biotech, academia/government, clinical research), Flow Cytometry, and Clinical Diagnostics.

While the website does offer traditional navigation, those links are secondary. The site is obviously built around the company's desire to serve its key market segments and stakeholders. According to Lawrence Bruder, CEO, the audience-centric organization was the obvious choice from the beginning: "Those individuals are the reason we are in business; the reason our employees come to work every day," said Mr. Bruder, "so given the importance of our website as a vehicle for two-way communication with them, it just made sense to focus it on their needs."

Guava Technologies encourages everyone interested in flow cytometry or the company to visit the site at http://www.guavatechnologies.com, and to let the company know what it can do to further improve the site based on their needs and interests.

Guava Technologies is a private biotechnology and medical device company. In 2001, it introduced the first commercial benchtop microcapillary flow cytometer with easy-to-use, assay-specific reagents and software. Since then, it has introduced numerous new systems and assays, always focusing on making flow cytometry more practical for life scientists and clinicians. Guava Systems do not require sheath fluid so accommodate smaller sample volumes, generate less waste, have lower daily operate costs, and are easier to set-up and maintain than traditional flow cytometers. And, all Guava Systems perform direct, absolute cell counts without reference beads. True to the company's goal, virtually any scientist or clinician can learn to operate a Guava System in less than one day.


'/>"/>
SOURCE Guava Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
2. Pre-eminent, web-based companies owe success to corporate venturing
3. Corporate Social Responsibility - Burden, sham, or golden opportunity?
4. Corporate venturing can nurture software success
5. Enrons dilemma: A corporate governance nightmare
6. Getting beyond the vortex of corporate mediocrity
7. Corporate control begins with a strong board
8. Directors more assertive in corporate governance
9. The black hole of corporate branding
10. Corporate Americas hidden deficit
11. Business professor launches corporate reporting study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
(Date:3/22/2017)... March 22, 2017 /PRNewswire/ - FACIT announced a ... or "Propellon"), a start-up created by FACIT focused ... FACIT,s investment, combined with non-dilutive capital, achieves a ... seed funding enables Propellon to accelerate the nomination ... for financing and/or entering a strategic partnership for ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation ... on the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, ... of therapeutic antibodies. , To meet this demand, the team at SCIEX ...
Breaking Biology Technology:
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: AWRE), ... that Richard P. Moberg has resigned, effective ... and Chief Financial Officer and Treasurer of Aware citing ... serve as a member of the Board of Directors ... Aware,s co-Chief Executive Officer and co-President, General Counsel has ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):